Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

I am really pleased to have with us ASCO's Chief Medical Officer and Senior Vice President for a conversation focusing on right-to-try policies.
At the most recent meeting, ASCO's delegation to the AMA House of Delegates were involved in resolutions related to Pharmacy Benefit Managers, opioids, billing for survivorship care plans, alcohol as a modifiable risk for cancer, and more.
As a pragmatic investigator and physician who has witnessed remarkable progress in the treatments we can now offer individuals with cancer, I believe the FDA’s support of more rapid and nimble testing and approval of new therapies should be applauded. 
My presidential year has provided me with the chance to advocate for ASCO’s principles to support our members and our patients. 
We examine how state-level health care policy may impact the care that we deliver to our patients with cancer, and why it's important for us to pay attention to and help shape bills and regulations moving in states.
Our vice president of Clinical Affairs breaks down the reporting changes you need to understand and address to avoid potential financial penalties in 2020.
All of us have the power to impact health care policy. ASCO's Advocate of the Year explains how easy it is to get involved, and how we need to focus on long-term success.
As the host of the ASCO in Action podcast series, I'll be interviewing leaders and experts in oncology about policy and practice issues. Our first episode is about representation in the oncology workforce.
ASCO urges Congress to protect Medicare beneficiaries with cancer and other medical conditions by passing additional legislation to avoid cuts to the program.
We are committed to supporting and promoting practical policy solutions that ensure patients with cancer have access to, and can afford, drugs vital to their treatment.
It's unacceptable that patients fall through the cracks of our health care system. Oncologists and patients need to sit at the table with policymakers to create real change.
Nominating Committee chair Dr. Lisa A. Carey encourages you to give a clear mandate to the Board by voting for your chosen leaders.
The most recent meeting of the AMA House of Delegates was a particularly important one for oncologists and cancer-related issues.
Dr. McAneny's broad expertise and insight on today’s challenging health care environment will greatly benefit the practice of medicine and our patients.
Preparing for the future starts with gaining clarity about the present state of oncology care. Our goal is for practices in all settings across the U.S. to provide feedback in the 2017 ASCO Practice Census.
If you say things of consequence, there may be consequences; but the alternative is to be inconsequential. Particularly in these tumultuous times for health care and research, we need to speak up!
Mr. Harvey D. Bichkoff offers a firsthand perspective of MACRA implementation at Marin Cancer Care, the private practice for which he serves as CEO.
We’re making progress in better understanding, and communicating, the many issues surrounding adverse events, although not as fast as we’d like. In the long run, our patients will benefit from all of these initiatives.

Pages


Advertisement